Primary hepatic amyloidosis: a mini literature review and five cases report
Journal Title: Annals of Hepatology - Year 2012, Vol 11, Issue 5
Abstract
Primary hepatic amyloidosis (PHA) is characterized by abnormal deposition of monoclonal immunoglobulin light chains (AL) in the liver. This rare condition is frequently undiagnosed or misdiagnosed and can be associated with poor prognosis. At present, the precise pathogenesis is not fully understood. Despite that hepatomegaly and elevated alkaline phosphatase (ALP) are present in most patients with PHA, no specific clinical markers have been identified. Staining of hepatic tissues with Congo Red is often regarded as the “gold standard”. Pharmacological therapy should aim to rapidly reduce the supply of misfolded amyloidoge-nic AL. High-dose intravenous melphalan (HDM) and autologous stem cell transplantation (ASCT) appear to be the most appropriate therapy but controversies still exist.
Authors and Affiliations
Ya-Dong Wang, Cai-Yan Zhao, Hong-Zhu Yin
Keywords
Related Articles
- EP ID EP78198
- DOI -
- Views 113
- Downloads 0
Giant cavernous hemangiomata of the liver: Watchful waiting, resection or transplantation?
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C
Background and rationale. The REPLACE study (NCT01571583) investigated telaprevir-based triple therapy in patients whohave recurrent genotype 1 hepatitis C virus (HCV) infection following liver transplantation and are o...
A comment from the Editor
PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C
Background. Hepatitis C virus (HCV) is associated with a higher prevalence of steatosis compared to the general population. Aim. Our aim was to assess the impact of PNPLA3 rs738409 G-allele on steatosis in HCV patients....
Levocetirizine induced hepatotoxicity in a patient with chronic urticaria